In The News Posted February 28, 2019 Share Posted February 28, 2019 BRIDGEWATER, N.J., Feb. 28, 2019 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the fourth quarter and year ended December 31, 2018. Summary of GAAP and Non-GAAP Combined and Adjusted Results (Unaudited; In thousands, except per... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.